Patent Office Issues Notice Of Allowance To InSite For DuraSite 2

Wednesday, July 3, 2013

Ocular Surgery News

InSite Vision received a notice of allowance from the U.S. Patent and Trademark Office for its DuraSite 2 drug delivery system, according to a news release.

Full Story

All of the following diagnoses are associated with cystoid macular edema (CME) on clinical examination and are also not with associated macular leakage on fluorescein angiography except for which one?
1. Nicotinic acid maculopathy
2. Idiopathic juxtafoveal (parafoveal) retinal telangiectasis (IJRT)
3. Goldman Favre Syndrome
4. Juvenile X-linked Retinoschisis
5. Enhanced S-cone dystrophy
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Patent Office Issues Notice Of Allowance To InSite For DuraSite 2

Comments

Quick Quiz

All of the following diagnoses are associated with cystoid macular edema (CME) on clinical examination and are also not with associated macular leakage on fluorescein angiography except for which one?

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

OPMI LUMERA 700 Surgical Microscope

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2